Impact of glycosylation and species origin on the uptake and permeation of IgGs through the nasal airway mucosa

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Simone Ladel - , Hochschule Biberach, Universität Ulm (Autor:in)
  • Frank Maigler - , Hochschule Biberach, Universität Ulm (Autor:in)
  • Johannes Flamm - , Hochschule Biberach, Universität Ulm (Autor:in)
  • Patrick Schlossbauer - , Hochschule Biberach (Autor:in)
  • Alina Handl - , Hochschule Biberach, Universität Ulm (Autor:in)
  • Rebecca Hermann - , Hochschule Biberach (Autor:in)
  • Helena Herzog - , Hochschule Biberach, Universität Ulm (Autor:in)
  • Thomas Hummel - , Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden (Autor:in)
  • Boris Mizaikoff - , Universität Ulm (Autor:in)
  • Katharina Schindowski - , Hochschule Biberach (Autor:in)

Abstract

Although we have recently reported the involvement of neonatal Fc receptor (FcRn) in intranasal transport, the transport mechanisms are far from being elucidated. Ex vivo porcine olfactory tissue, primary cells from porcine olfactory epithelium (OEPC) and the human cell line RPMI 2650 were used to evaluate the permeation of porcine and human IgG antibodies through the nasal mucosa. IgGs were used in their wild type and deglycosylated form to investigate the impact of glycosylation. Further, the expression of FcRn and Fc-gamma receptor (FCGR) and their interaction with IgG were analyzed. Comparable permeation rates for human and porcine IgG were observed in OEPC, which display the highest expression of FcRn. Only traces of porcine IgGs could be recovered at the basolateral compartment in ex vivo olfactory tissue, while human IgGs reached far higher levels. Deglycosylated human IgG showed significantly higher permeation in comparison to the wild type in RPMI 2650 and OEPC, but insignificantly elevated in the ex vivo model. An immunoprecipitation with porcine primary cells and tissue identified FCGR2 as a potential interaction partner in the nasal mucosa. Glycosylation sensitive receptors appear to be involved in the uptake, transport, but also degradation of therapeutic IgGs in the airway epithelial layer.

Details

OriginalspracheEnglisch
Aufsatznummer1014
Seiten (von - bis)1-24
Seitenumfang24
FachzeitschriftPharmaceutics
Jahrgang12
Ausgabenummer11
PublikationsstatusVeröffentlicht - Nov. 2020
Peer-Review-StatusJa

Externe IDs

ORCID /0000-0001-9713-0183/work/151982927

Schlagworte

ASJC Scopus Sachgebiete

Schlagwörter

  • Barrier model, Blood-brain barrier, Drug delivery, IgG permeation, Nose-to-brain, Olfactory epithelium, Primary cells, Respiratory epithelium, RPMI 2650